309 related articles for article (PubMed ID: 16652380)
1. Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings.
Burgio KL; Goode PS; Richter HE; Locher JL; Roth DL
Neurourol Urodyn; 2006; 25(5):411-7. PubMed ID: 16652380
[TBL] [Abstract][Full Text] [Related]
2. Re: Burgio KL, Goode PS, Richter HE, et al. 2006. Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings. Neurourol Urodynam 25:411-417.
Brown JS
Neurourol Urodyn; 2007; 26(3):456. PubMed ID: 17304526
[No Abstract] [Full Text] [Related]
3. Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study.
Urinary Incontinence Treatment Network (UITN)
Contemp Clin Trials; 2007 Jan; 28(1):48-58. PubMed ID: 16919506
[TBL] [Abstract][Full Text] [Related]
4. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).
Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS
Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182
[TBL] [Abstract][Full Text] [Related]
5. Rating improvements in urinary incontinence: do patients and their physicians agree?
Tannenbaum C; Brouillette J; Corcos J
Age Ageing; 2008 Jul; 37(4):379-83. PubMed ID: 18586834
[TBL] [Abstract][Full Text] [Related]
6. "Unblinding" in randomized controlled drug trials for urinary incontinence: Implications for assessing outcomes when adverse effects are evident.
DuBeau CE; Khullar V; Versi E
Neurourol Urodyn; 2005; 24(1):13-20. PubMed ID: 15570576
[TBL] [Abstract][Full Text] [Related]
7. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
8. Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women.
Burgio KL; Goode PS; Richter HE; Markland AD; Johnson TM; Redden DT
J Urol; 2010 Aug; 184(2):598-603. PubMed ID: 20639023
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P
Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727
[TBL] [Abstract][Full Text] [Related]
10. Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinence.
Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Meadows ES; Yalcin I; Muram D;
Obstet Gynecol; 2005 Oct; 106(4):767-73. PubMed ID: 16199634
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of pelvic floor muscle exercise therapy supplemented with a health education program to promote long-term adherence among women with urinary incontinence.
Alewijnse D; Metsemakers JF; Mesters IE; van den Borne B
Neurourol Urodyn; 2003; 22(4):284-95. PubMed ID: 12808702
[TBL] [Abstract][Full Text] [Related]
12. Quality-of-life impact and treatment of urinary incontinence in ethnically diverse older women.
Huang AJ; Brown JS; Kanaya AM; Creasman JM; Ragins AI; Van Den Eeden SK; Thom DH
Arch Intern Med; 2006 Oct; 166(18):2000-6. PubMed ID: 17030834
[TBL] [Abstract][Full Text] [Related]
13. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery.
Mahajan ST; Elkadry EA; Kenton KS; Shott S; Brubaker L
Am J Obstet Gynecol; 2006 Mar; 194(3):722-8. PubMed ID: 16522404
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of the effectiveness of pelvic floor therapies for urodynamic stress and mixed incontinence.
Williams KS; Assassa RP; Gillies CL; Abrams KR; Turner DA; Shaw C; Haslam J; Mayne C; McGrother CW;
BJU Int; 2006 Nov; 98(5):1043-50. PubMed ID: 17034605
[TBL] [Abstract][Full Text] [Related]
15. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
Rovner ES; Kreder K; Sussman DO; Kaplan SA; Carlsson M; Bavendam T; Guan Z
J Urol; 2008 Sep; 180(3):1034-41. PubMed ID: 18639297
[TBL] [Abstract][Full Text] [Related]
16. Measuring health-related quality of life in women with urogenital dysfunction: the urogenital distress inventory and incontinence impact questionnaire revisited.
van der Vaart CH; de Leeuw JR; Roovers JP; Heintz AP
Neurourol Urodyn; 2003; 22(2):97-104. PubMed ID: 12579625
[TBL] [Abstract][Full Text] [Related]
17. The effects of multidimensional exercise treatment on community-dwelling elderly Japanese women with stress, urge, and mixed urinary incontinence: a randomized controlled trial.
Kim H; Yoshida H; Suzuki T
Int J Nurs Stud; 2011 Oct; 48(10):1165-72. PubMed ID: 21459381
[TBL] [Abstract][Full Text] [Related]
18. [Development of a questionnaire to measure the effect of urinary incontinence on female sexuality: a reliability and validity study].
Komatsu H; Kojima M; Suzuki K; Minamikawa M; Okamitsu K; Nomura M; Itou E
Kango Kenkyu; 1996; 29(5):386-98. PubMed ID: 9282013
[TBL] [Abstract][Full Text] [Related]
19. Test-retest reliability, validity, and sensitivity to change of the urogenital distress inventory and the incontinence impact questionnaire.
Hagen S; Hanley J; Capewell A
Neurourol Urodyn; 2002; 21(6):534-9. PubMed ID: 12382243
[TBL] [Abstract][Full Text] [Related]
20. A case series to pilot cognitive behaviour therapy for women with urinary incontinence.
Garley A; Unwin J
Br J Health Psychol; 2006 Sep; 11(Pt 3):373-86. PubMed ID: 16870050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
